Pnc Financial Services Group, Inc. Collegium Pharmaceutical, Inc Transaction History
Pnc Financial Services Group, Inc.
- $190 Billion
- Q1 2025
A detailed history of Pnc Financial Services Group, Inc. transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 679 shares of COLL stock, worth $20,016. This represents 0.0% of its overall portfolio holdings.
Number of Shares
679
Previous 575
18.09%
Holding current value
$20,016
Previous $16,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding COLL
# of Institutions
255Shares Held
37.2MCall Options Held
61.1KPut Options Held
5.8K-
Black Rock Inc. New York, NY5.79MShares$171 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY3MShares$88.4 Million2.57% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$77.8 Million1.67% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.25MShares$66.2 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA1.63MShares$48.1 Million0.01% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.01B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...